America December 20, 2024
Former Biopharmaceutical Executive Pays $156K to Settle SEC Insider Trading Claims
A former biopharmaceutical executive has agreed to pay nearly $156,000 to resolve U.S. Securities and Exchange Commission (SEC) allegations that…